These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 36927803)
21. Co-Delivery of Paclitaxel by a Capsaicin Prodrug Micelle Facilitating for Combination Therapy on Breast Cancer. Lan Y; Sun Y; Yang T; Ma X; Cao M; Liu L; Yu S; Cao A; Liu Y Mol Pharm; 2019 Aug; 16(8):3430-3440. PubMed ID: 31199661 [TBL] [Abstract][Full Text] [Related]
22. Enhanced antitumor efficacy by d-glucosamine-functionalized and paclitaxel-loaded poly(ethylene glycol)-co-poly(trimethylene carbonate) polymer nanoparticles. Jiang X; Xin H; Gu J; Du F; Feng C; Xie Y; Fang X J Pharm Sci; 2014 May; 103(5):1487-96. PubMed ID: 24619482 [TBL] [Abstract][Full Text] [Related]
23. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
24. A Dual-Targeting Liposome Enhances Triple-Negative Breast Cancer Chemoimmunotherapy through Inducing Immunogenic Cell Death and Inhibiting STAT3 Activation. Luo K; Yang L; Yan C; Zhao Y; Li Q; Liu X; Xie L; Sun Q; Li X Small; 2023 Oct; 19(40):e2302834. PubMed ID: 37264710 [TBL] [Abstract][Full Text] [Related]
25. Cascade-Responsive Hierarchical Nanosystems for Multisite Specific Drug Exposure and Boosted Chemoimmunotherapy. Zhang J; Zhang Y; Zhao B; Lv M; Chen E; Zhao C; Jiang L; Qian H; Huang D; Zhong Y; Chen W ACS Appl Mater Interfaces; 2021 Dec; 13(49):58319-58328. PubMed ID: 34855343 [TBL] [Abstract][Full Text] [Related]
26. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma. Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654 [TBL] [Abstract][Full Text] [Related]
27. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression. Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233 [TBL] [Abstract][Full Text] [Related]
28. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Song Y; Tang C; Yin C Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030 [TBL] [Abstract][Full Text] [Related]
29. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors. Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250 [TBL] [Abstract][Full Text] [Related]
30. Dual stimuli-responsive dendronized prodrug derived from poly(oligo-(ethylene glycol) methacrylate)-based copolymers for enhanced anti-cancer therapeutic effect. Luo Q; Lin L; Huang Q; Duan Z; Gu L; Zhang H; Gu Z; Gong Q; Luo K Acta Biomater; 2022 Apr; 143():320-332. PubMed ID: 35235863 [TBL] [Abstract][Full Text] [Related]
31. Endocytosis-mediated triple-activable prodrug nanotherapeutics potentiating therapeutic efficacy and security towards solid tumors. Fu S; Ma S; Peng X; Qiao H; Zang W; Ye J; Zang W; Li M; Shi K; Ye X; Sun W; Zhai Y Colloids Surf B Biointerfaces; 2022 Oct; 218():112723. PubMed ID: 35932558 [TBL] [Abstract][Full Text] [Related]
32. Self-Assembled Nanoparticles from the Amphiphilic Prodrug of Resiquimod for Improved Cancer Immunotherapy. Li JX; Shu N; Zhang YJ; Tong QS; Wang L; Zhang JY; Du JZ ACS Appl Mater Interfaces; 2024 May; 16(20):25665-25675. PubMed ID: 38735053 [TBL] [Abstract][Full Text] [Related]
33. Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy. Feng B; Hou B; Xu Z; Saeed M; Yu H; Li Y Adv Mater; 2019 Oct; 31(40):e1902960. PubMed ID: 31423683 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma: Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747 [TBL] [Abstract][Full Text] [Related]
36. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting. Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430 [TBL] [Abstract][Full Text] [Related]
37. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy. Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771 [TBL] [Abstract][Full Text] [Related]
38. An albumin-bound drug conjugate of paclitaxel and indoleamine-2,3-dioxygenase inhibitor for enhanced cancer chemo-immunotherapy. Hu Z; Zheng B; Xu J; Gao S; Lu W Nanotechnology; 2020 May; 31(29):295101. PubMed ID: 32203949 [TBL] [Abstract][Full Text] [Related]
39. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related]
40. Co-delivery of doxorubicin and paclitaxel by reduction/pH dual responsive nanocarriers for osteosarcoma therapy. Li Y; Hou H; Zhang P; Zhang Z Drug Deliv; 2020 Dec; 27(1):1044-1053. PubMed ID: 32633576 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]